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Abstract
Ca2+ sensitivity of smooth muscle (SM) contraction is determined by CPI-17, an inhibitor
protein for myosin light chain phosphatase (MLCP). CPI-17 is highly expressed in mature SM
cells, but the expression level varies under pathological conditions. Here, we determined the
expression of CPI-17 in embryonic SM tissues and arterial neointimal lesions using
immunohistochemistry. As seen in adult animals, the predominant expression of CPI-17 was
detected at SM tissues on mouse embryonic sections, whereas MLCP was ubiquitously
expressed. Compared with SM α-actin, CPI-17 expression doubled in arterial SM from
embryonic day E10 to E14. Like SM α-actin and other SM marker proteins, CPI-17 was
expressed in embryonic heart, and the expression was down-regulated at E17. In adult rat, CPI17 expression level was reduced to 30 % in the neointima of injured rat aorta, compared with
the SM layers, whereas the expression of MLCP was unchanged in both regions. Unlike other
SM proteins, CPI-17 was detected at non-SM organs in the mouse embryo, such as embryonic
neurons and epithelium. Thus, CPI-17 expression is reversibly controlled in response to the
phenotype transition of SM cells that restricts the signal to differentiated SM cells and particular
cell types.
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Introduction
Vascular smooth muscle (SM) contraction is triggered by the phosphorylation of myosin
light chain (MLC), which is controlled through two major signaling pathways: the activation of
MLC kinase (MLCK) and the inhibition of MLC phosphatase (MLCP). The inhibition of MLCP
occurs upon G-protein activation in response to agonist stimuli.

MLCP activity is increased in

response to nitric oxide production causing myosin dephosphorylation and SM relaxation. Thus,
MLCP activity plays an important role in the regulation of both SM contraction and relaxation.
MLCP is a heterotrimeric enzyme, consisting of a delta isoform of protein phosphatase-1
catalytic subunit (PP1∂), a myosin targeting subunit (MYPT1), and an accessory M21 subunit
(Hartshorne et al. 2004). MYPT1 tethers PP1∂ to myosin filaments and determines the substrate
specificity (Hartshorne et al. 2004). MLCP activity is suppressed via the bi-phasic
phosphorylation of MYPT1 and an inhibitor protein for MLCP, CPI-17 (Dimopoulos et al. 2007).
CPI-17, a 17-kDa cytosolic protein, potently and selectively inhibits MLCP in SM when it is
phosphorylated at Thr38 (Eto et al. 1995; Eto et al. 2004). The phosphorylation of CPI-17 occurs
in response to agonist stimulation, and it reversibly declines in response to NO/cGMP (Etter et
al. 2001; Dimopoulos et al. 2007), suggesting a critical role of CPI-17 in the regulation of MLC
phosphorylation and SM contraction.
In adult animals, MYPT1 is ubiquitously expressed (Okubo et al. 1994), whereas CPI-17
4
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is predominantly expressed at SM tissues and brain in adult rat (Woodsome et al. 2001; Eto et
al. 2002). Among SM tissues, CPI-17 expression is higher in tonic muscles, such as arteries, but
lower in phasic muscles, such as ileum and urinary bladder. Importantly, the expression level of
CPI-17 in each tissue correlates with the extent of PKC-induced contraction (Woodsome et al.
2001). Furthermore, arterial SM from adult farm chicken expresses undetectable level of
endogenous CPI-17 and produces a negligible level of the force in response to G-protein
activation (Kitazawa et al. 2004). Thus, the expression level of CPI-17 is a critical determinant of
the extent of the myosin phosphorylation and SM contraction induced through G-proteinmediated signals.
Accumulating evidence shows that up- and down-regulation of CPI-17 occurs under
pathological conditions, such as inflammation, asthma, diabetes, and hypoxia, resulting in
abnormal SM contraction (Ohama et al. 2003; Dakshinamurti et al. 2005; Sakai et al. 2005;
Chang et al. 2006). It is known that these pathological as well as physiological factors, such as
an increase in blood flow, affect the differentiation state of SM cells causing the reversible
transition between a contractile and proliferative phenotype (Owens et al. 2004). A group of
transcriptional cofactors, myocardin and other family members, Myocardin Related Transcription
Factors (MRTFs), play an important role in orchestrating the gene expression of SM marker
proteins, including SM α-actin, SM myosin heavy chain (MHC), SM22 and calponin, through
5
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serum-response transcription factor (Wang and Olson. 2004). However, it is not yet known
whether the phenotype transition of SM cells alters the expression of CPI-17.

In the present

study, we examined CPI-17 expression at three different stages during mouse embryo
development and at de-differentiated neointimal lesions at the injured site of rat aorta. The
results revealed SM differentiation-dependent regulation of CPI-17 expression, as well as the
novel expression of CPI-17 in embryonic epithelium. This provides evidence that the regulation
of MLCP activity is programmed at each locus through the transcription of CPI-17.

6

Kim et al. Histochem Cell Biol.
Submitted on 11/4/08, Revised 1/7/09, 2/6/09, 3/23/09, 4/9/09
Materials and Methods
Mouse embryo tissue sections: Sagittal sections of paraffin embedded mouse whole embryo
at embryonic day 10, 14, and 17 (E10, 14, 17) were purchased from Zyagen (Zyagen, San
Diego, CA, USA).
Aorta injury model: Aorta injury was performed in Sprague Dawley rats (7 to 9 w) using a
balloon catheter introduced through the carotid artery. Vessels were harvested 14 days later, as
described previously (Jin et al. 2007). The animal protocol was approved by ICUC at University
of Virginia.
Immunohistochemistry of sections of mouse embryo and aorta: All processes were done at
room temperature. Deparaffinization and rehydration were performed by successive immersion
for 10 min in each of the following solutions:

xylene, ethanol (100%, 90%, 80%, 70%), and

distilled water. After a 5-min permeabilization 0.1% Triton X-100 in PBS and then 1-h blocking
with 3% BSA/PBS, sections were incubated for 2 h with primary antibody (1:100 in BSA/PBS).
The primary antibodies used were rabbit anti-CPI-17 (Woodsome et al. 2001), mouse anti-SM
α-actin (Sigma-Aldrich Inc., Saint Louis, MO, USA), mouse anti-MYPT1 (Babco, Richmond, CA,
USA). Mouse embryo sections were incubated for 1 h with alkaline phosphatase (AP)conjugated secondary antibody for rabbit or mouse IgG at 1:500 dilution. Dual color stain of
mouse embryo section was carried out for 1 h with a mixture of the secondary antibody
7
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conjugated with AP (1:100) and cy5 (1:500). Rat aorta sections were stained for 1 h with a
mixture of Cy3- and Cy5-conjugated secondary antibodies (1:500). Specimen AP was visualized
with Vector Red AP Substrate Kit I that develop visible red color as well as red fluorescence
(Vector laboratories Inc., Burlingame, CA, USA). Bright field color images of mouse whole
embryo with red stain of AP substrate kit (Fig. 1) were taken using LeicaMZFLIII (Leica
Microsystems Inc., Bannockburn, IL, USA) with a color CCD camera. Fluorescence images
were captured using Olympus IX70 (Olympus America Inc., NY, USA) equipped with CoolSNAP
ES2 CCD camera (Roper Sci), CARV II spinning desk confocal unit (BD Biosciences) and
Cy3/Cy5 and GFP/Texas Red filter sets from Chroma. (Fig. 2-4). Image capturing, densitometry
of fluorescence intensity, and digital image processing were carried out using IPLab software
(BD Biosciences). Pseudo colors, green for SM α−actin, and red for CPI-17 and MYPT1, were
given for all the fluorescence images. There was no noticeable auto-fluorescence under Cy3,
Texas Red and Cy5 filters, except for the signal derived from red blood cells in arterial lumen,
which was used as a marker to find arteries. The staining without primary antibody gave no
detectable fluorescence signal. Representative images are shown in the figures. 3,3’diaminobenzidine (DAB)/Hematoxylin double stain was performed using DAB substrate kit and
VECTOR Hematoxylin (VECTOR laboratories Inc., Burlingame, CA, USA).

Color images were

captured using Nikon TS100 inverted microscope with Coolpix 995 digital camera.
8
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Statistical Analysis: Student's t-test analysis assuming an equal distribution was carried out
using Excel software to compare to two groups. P values < 0.01 were regarded as statistically
significant and indicated with ** in the figures.
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Results
Expression of CPI-17 in mouse embryo. Fig 1 shows immunostaining for CPI-17 (Fig. 1 A and
B), MYPT1 (C, D), and SM α−actin (E, F) in mouse embryonic slices at E10 and 17. In E10 slice,
CPI-17 signal (red) was exclusively detected at heart (h), intercostal muscle (ic), and neuronal
tissues (n) (Fig. 1, panel A). The expression of CPI-17 was more prominent in E17 embryonic
SM tissues such as aorta (a), tongue (t) esophagus (e), intestine (i) lung (lu), heart (h), as well
as neuronal tissues (n) (Panel B). There is no significant background except for intestine in E17
(G, H), which is probably derived from endogenous alkaline phosphatases. On the other hand,
MYPT1 existed in all organs examined in the E10 and 17 slices, indicating the ubiquitous
expression of MLCP (Fig. 1 C, D). Overall, the expression pattern of CPI-17 was similar to that
of SM α−actin (E, F) and SM MHC (data not shown). However, there were significant
differences between the expression of CPI-17 and SM α−actin at multiple loci (also see Fig. 4),
such as neuronal tissues (n), where the expression of SM α−actin was negligible.

Expression of CPI-17 in arterial SM and cardiac muscle during embryonic development.
The expression levels of CPI-17 at embryonic heart and artery were determined by semiquantitative immunofluorescence (Fig. 2). SM α−actin was used as a control, because it is
expressed at the early stage during vascular development and the expression is insensitive to
10
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environmental factors (Aikawa et al. 1993; Owens et al. 2004). The dual-color stain of mouse
embryonic slices showed co-expression of CPI-17 (red) and SM α−actin (green) in arterial SM
cells (Fig. 2A, and B) and cardiac muscle (panel C). The relative expression level of CPI-17
appeared to be higher in the arterial SM at E14, compared to E10 (Fig. 2B). The staining
intensity of CPI-17 varied in each artery, although it did not depend on the location or the size of
artery. Fig. 2D shows the relative expression of CPI-17 normalized with the level of SM α−actin.
The ratio of CPI-17 to SM α-actin doubled in arterial SM from E10 to E14 and sustained at E17.
SM marker proteins are expressed in embryonic cardiac muscle due to the early activity of
myocardin (Wang and Olson. 2004). Indeed, both CPI-17 and SM α−actin were detected in
cardiac muscle at E10 and E17 (Fig. 2C). In the E10 slice, the ratio of CPI-17 expression to SM
α−actin was 2-fold higher in heart compared to arteries. However, unlike arterial SM, the relative
expression of CPI-17 significantly decreased from E10 to E17 (Fig. 2D).

Expression of CPI-17 and MLCP in the neointimal region in an aorta injury model. The
neointimal formation of adult rat aorta was initiated by removing the endothelium using a wire
catheter. Sections were subjected to immunohistochemistry with DAB/hematoxylin stain (Fig. 3
and Supplemental figure S1). After endothelium removal SM cells outgrew from the SM layers
between elastin sheets to the lumen, where the cells are disoriented (Fig. 3A). The neointimal
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lesions were visible at day 7 (D7) and thickened at day 14 (D14) after the surgery (Jin et al.
2007). The conventional immunohistochemistry showed the expression of CPI-17 at the
neointimal lesions, whereas the signal at the neointimal cells was weaker, compared with SM
layers (Fig. 3A left).
3A, right).

No signal was detected in the specimen without the primary antibody (Fig.

CPI-17 stain was more prominent in the neointima, when intense color development

was carried out (Supplemental figure S1).

Semi-quantitative dual-color immunofluorescence

was performed to determine the expression of CPI-17 in the SM layer and the neointima (Fig.
3B and C). As reported previously, SM α−actin was expressed in the cells at the neointima as
well as in those at the SM layer (Fig. 3B and C, green) (Aikawa et al. 1993). The expression
levels of CPI-17 were unchanged in SM layer of the untreated D0 control and the injured D14
aorta (Fig. 3C, marked as SM). The ratio of CPI-17 expression to SM α−actin in the neointima
(Fig. 3C, asterisk) declined to 30 ± 2 % of that of the SM layer at D0 and D14 (p<0.01) (Fig. 3D).
In contrast, MYPT1 expression was not significantly different in the neointima and media (Fig.
3E). Thus, the expression of CPI-17 is reversibly regulated in response to SM differentiation and
de-differentiation.

Expression of CPI-17 in non-arterial organs. CPI-17 was also detected in embryonic intestine,
lung, ganglion (Fig. 4) and other tissues such as trachea and esophagus (data not shown).
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Bottom panel indicates the boxed area in the merged image. In intestine, CPI-17 was equally
and prominently expressed in both external and internal layers of SM in the intestinal wall,
whereas SM α−actin was present in both layers but predominantly expressed in the internal SM
layer (Fig. 4 left). Furthermore, a significant amount of CPI-17 was detected in intestinal
epithelium, where SM α−actin expression was negligible (Fig. 4, left, box). In the condensed
embryonic lung, the expression of CPI-17 was prominent in most of cells including epithelial
cells of alveoli (al) (Fig. 4, center), whereas SM α−actin was exclusively expressed in SM layers
of artery (at), and bronchiole (arrow). The epithelial expression of CPI-17 at the alveolus was
evident in the magnified image (Fig. 4, bottom row center).

Epithelial staining of CPI-17 was

also observed in trachea and esophagus (data not shown). The punctate staining pattern of
CPI-17 in Fig. 4 (right) indicates the expression in neuronal cells (n, see also boxed area lower
row right) and precursor bone cells (b), where the expression of SM α−actin was undetectable,
whereas arterial SM layer shows both SM α−actin and CPI-17 in the same section (Fig. 4, right,
at, see also boxed area lower row right). No expression of SM MHC was detected in epithelium,
neuronal or bone cells (data not shown). Thus, the expression of CPI-17 is apparently
distinguishable from that of SM marker proteins at particular loci.

13

Kim et al. Histochem Cell Biol.
Submitted on 11/4/08, Revised 1/7/09, 2/6/09, 3/23/09, 4/9/09
Discussion
CPI-17 was up- and down-regulated in response to SM differentiation and dedifferentiation. In contrast, the expression of MYPT1 was constant at any locus and stage, unlike
SM-type MLCK, whose promoter is controlled via a myocardin signal (Yin et al. 2006). The
fluctuation of CPI-17 expression causes variation in the ratio of CPI-17 expression to MLCP at
each locus. (DELETED) A lack of the expression or the phosphorylation of CPI-17 via Ca2+dependent PKC results in the slower force development of SM tissues (Kitazawa et al. 2004;
Dimopoulos et al. 2007). Thus, the ratio of CPI-17 to MLCP determines the rapidity and
magnitude of the agonist-induced SM contraction. It is known that heart rate and blood flow of
embryo significantly increase from E10 to E14 (Keller et al. 1996). Therefore, the histological
data suggest that the embryonic arterial SM cells increase the contractility through the
expression of CPI-17 in response to a gain of cardiac function and an increase in blood flow. In
contrast, CPI-17 is down-regulated in the proliferative phenotype of SM cells, such as cells at
neointima and cultured SM cells. It is possible that mechanical stresses and/or agonist signals
alter the signal into MLCP regulation upon the phenotype transition, and this will be a subject for
further study.
Immunohistochemistry detected significant levels of CPI-17 expression in the embryonic
heart, although CPI-17 is negligible in adult rat heart (Woodsome et al. 2001). The relative
14
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expression of CPI-17 was decreased from E10 to E17, suggesting that CPI-17 gene becomes
suppressed after the maturation of cardiac muscle. It is consistent with the other SM marker
proteins whose expression is turned off in adult heart (Ruzicka and Schwartz. 1988). MYPT1
was also detected in embryonic heart (Fig. 1C and D), suggesting that CPI-17 may be involved
in the regulation of MLCP activity in embryonic cardiac muscle, although the roles of myosin
phosphorylation and MLCP in embryonic heart are still unknown. In contrast, embryonic skeletal
muscle at E10 does not express CPI-17. Wu et al reported that MYPT1 gene undergoes downregulation upon the differentiation of myoblasts in parallel to the up-regulation of MYPT2, a
close member in the MYPT1 family (Wu et al. 2003). Indeed, MYPT1 is not detected in adult
skeletal muscle (Okubo et al. 1994). The phosphorylation of myosin II is required for the
myotube formation of myoblasts (Wu et al. 2003). Consistent with this, the expression of MYPT1
was evident in the embryonic skeletal muscle at E10 and E17. CPI-17 seems to be unnecessary
for the regulation of MLCP in myotube formation.
As seen in adult animals, CPI-17 is expressed in embryonic neuronal cells.
Furthermore, this is the first report that a significant amount of CPI-17 is detected in embryonic
epithelial cells. The epithelial expression of CPI-17 in embryonic lung disagrees with the results
from the adult tissue (Woodsome et al. 2001). One possibility is that the condensed embryonic
lung emphasizes the CPI-17 staining at epithelium, compared with inflated adult lung. Indeed, a
15
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trace amount of CPI-17 was detected in lung epithelium from adult rats (Woodsome et al. 2001).
The role of CPI-17 in epithelial cells is unknown. Recently, a group of tumor cells were reported
to express a high amount of CPI-17 that causes hyper-phosphorylation of merlin/NF2 oncogene
product and transformation of the cells (Jin et al. 2006). These tumor cells are derived from
epithelial cells. It is possible that CPI-17 functions in the regulation of epithelial cell proliferation.
Our findings will provide new avenues for research studying the role of CPI-17 in the regulation
of MLCP at non-SM cells.
The most important finding of the present study is that the expression of CPI-17 is
reversibly regulated in arterial SM cells. It is similar to other SM marker proteins, such as SM
myosin heavy chain, that is regulated upon the phenotype transition of SM via myocardin and
MRTFs (Aikawa et al. 1993; Wang and Olsen 2004). However, it is unclear whether CPI-17
expression is controlled via myocardin signal. There are significant differences in the expression
profiles of CPI-17 and SM α−actin. Dysregulation of CPI-17 expression can cause disorders in
the regulation of SM contraction, so that the molecular basis of the gene regulation seems to
deserve further investigation.
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Figure legends
Fig. 1. Immunohistochemistry showing the presence of CPI-17, MYPT1, and SM α−actin
in
α−
tissue sections of mouse embryos. Sagittal sections of mouse embryo at E10 and E17 were
stained with anti-CPI-17 (A, B), MYPT1 (C, D), and SM α−actin (E, F) or without primary
antibody as background (G, H). Red color was developed for 7 min (CPI-17) and for 6 min (SM
α−actin and MYPT1). a, aorta; e, esophagus; h, heart; i, intestine; ic, intercostal muscle; li, liver;
lu, lung; n, neuronal cells; t, tongue
Fig. 2. Immunofluorescence of CPI-17 and SM α−actin
in artery and heart in sagittal
α−
sections of mouse embryo. All the samples were stained under identical conditions including
a 3.5-min color development. (A) Dual color Images for the presence of CPI-17 (red) and SM
α−actin (green) in artery at E14. (B) Merged images of CPI-17 and SM α−actin in artery. The
dots in the lumen are auto-fluorescence from red cells. (C) The expression of CPI-17 and SM
α−actin in embryonic heart at E10 and 17. a, aorta; h, heart (D) The ratio of CPI-17 expression
to SM α−actin in arterial SM and cardiac muscle. Mean values ± SEM were obtained from the
staining intensity of CPI-17 normalized to that of SM α−actin at randomly-picked regions of 10
arteries in the slice of E10, 14, 17 and 10 different spots in cardiac muscle of the E10 and 17. **
indicates statistical significance (p<0.01).
Fig. 3. Expression of CPI-17, MYPT1, and SM α−actin
in neointimal lesions of rat adult
α−
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aorta. (A) DAB/hematoxylin dual-color stain of transverse sections of aorta at 7 days after the
surgery for denuding the endothelium. Staining was carried out using with anti-CPI-17 and
peroxidase-labeled secondary antibody.
primary antibody.

Right panel shows control experiments without the

(B, C) Indirect immunohistochemistry with Cy3- and cy5-conjugated

antibodies showing the presence of CPI-17 (B) or MYPT1 (C) in red with SM α−actin in green in
transverse sections of aorta before (D0) and at 14 days after the surgery for denuding the
endothelium (D14). Asterisk indicates the neointima lesion and SM indicates smooth muscle
layers in the media. (D, E) The relative expression level of CPI-17 (D) and MYPT1 (E).

Mean

values ± SEM were obtained from the ratio of intensity at 20-28 different spots of SM layer and
neointima of injured aorta.
Fig. 4. Immunofluorescence staining for the presence of CPI-17 in non-arterial embryonic
organs. An E17 embryo section was subjected to dual color immunofluorescence for the
expression of CPI-17 (red) and SM α−actin (green). Confocal images focused on intestine (left),
lung (center), and neuronal area (right) are shown. Color was developed for 7 min. Bottom
panels show images with higher magnifications at the boxed area. SM, SM layer; epi, epithelial
cells; *, alveolus lumen; at, artery; n, neuronal cells; b, precursor bone cells.
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